Literature DB >> 16565085

Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin.

Woojin Jeong1, Sung Jun Park, Tong-Shin Chang, Duck-Yeon Lee, Sue Goo Rhee.   

Abstract

Among many proteins with cysteine sulfinic acid (Cys-SO2H) residues, the sulfinic forms of certain peroxiredoxins (Prxs) are selectively reduced by sulfiredoxin (Srx) in the presence of ATP. All Srx enzymes contain a conserved cysteine residue. To elucidate the mechanism of the Srx-catalyzed reaction, we generated various mutants of Srx and examined their interaction with PrxI, their ATPase activity, and their ability to reduce sulfinic PrxI. Our results suggest that three surface-exposed amino acid residues, corresponding to Arg50, Asp57, and Asp79 of rat Srx, are critical for substrate recognition. The presence of the sulfinic form (but not the reduced form) of PrxI induces the conserved cysteine of Srx to take the gamma-phosphate of ATP and then immediately transfers the phosphate to the sulfinic moiety of PrxI to generate a sulfinic acid phosphoryl ester (Prx-Cys-S(=O)OPO3(2-)). This ester is reductively cleaved by a thiol molecule (RSH) such as GSH, thioredoxin, and dithiothreitol to produce a disulfide-S-monoxide (Prx-Cys-S(=O)-S-R). The disulfide-S-monoxide is further reduced through the oxidation of three thiol equivalents to complete the catalytic cycle and regenerate Prx-Cys-SH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565085     DOI: 10.1074/jbc.M511082200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Harnessing Redox Cross-Reactivity To Profile Distinct Cysteine Modifications.

Authors:  Jaimeen D Majmudar; Aaron M Konopko; Kristin J Labby; Christopher T M B Tom; John E Crellin; Ashesh Prakash; Brent R Martin
Journal:  J Am Chem Soc       Date:  2016-02-05       Impact factor: 15.419

Review 2.  Mitochondrial thiols in the regulation of cell death pathways.

Authors:  Fei Yin; Harsh Sancheti; Enrique Cadenas
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

Review 3.  The peroxiredoxin repair proteins.

Authors:  Thomas J Jönsson; W Todd Lowther
Journal:  Subcell Biochem       Date:  2007

Review 4.  Discovering mechanisms of signaling-mediated cysteine oxidation.

Authors:  Leslie B Poole; Kimberly J Nelson
Journal:  Curr Opin Chem Biol       Date:  2008-03-07       Impact factor: 8.822

Review 5.  Redox-based regulation of signal transduction: principles, pitfalls, and promises.

Authors:  Yvonne M W Janssen-Heininger; Brooke T Mossman; Nicholas H Heintz; Henry J Forman; Balaraman Kalyanaraman; Toren Finkel; Jonathan S Stamler; Sue Goo Rhee; Albert van der Vliet
Journal:  Free Radic Biol Med       Date:  2008-03-27       Impact factor: 7.376

Review 6.  Thiol chemistry in peroxidase catalysis and redox signaling.

Authors:  Alberto Bindoli; Jon M Fukuto; Henry Jay Forman
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

7.  Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response.

Authors:  K Lei; D M Townsend; K D Tew
Journal:  Oncogene       Date:  2008-05-05       Impact factor: 9.867

Review 8.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

9.  Circadian rhythm of hyperoxidized peroxiredoxin II is determined by hemoglobin autoxidation and the 20S proteasome in red blood cells.

Authors:  Chun-Seok Cho; Hyun Ju Yoon; Jeong Yeon Kim; Hyun Ae Woo; Sue Goo Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

10.  Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies.

Authors:  Qiou Wei; Hong Jiang; Connie P Matthews; Nancy H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.